When administered therapeutically, GLP-1 receptor agonists work through several mechanisms: Enhancing insulin secretion from pancreatic beta cells in a glucose-dependent manner [1] [4] Suppressing glucagon release from alpha cells, reducing hepatic glucose output Slowing gastric emptying , which helps moderate post-meal blood glucose rises Promoting satiety through central nervous system pathways, potentially supporting weight reduction Investigational transdermal GLP-1 delivery systems typically utilise specialised technologies such as microneedles or active delivery methods rather than conventional patches, as GLP-1 molecules are large peptides that do not easily penetrate the skin barrier
Additionally, improved glycaemic control may positively influence pre-existing diabetes-related skin conditions such as acanthosis nigricans (darkened skin patches) or diabetic dermopathy
Zinc plays a crucial role in taste and smell perception
The Human Tripeptide GHK-Cu in Prevention of Oxidative Stress and Tissue Remodeling (Pickart et al., 2012) This article reviews how GHK-Cu has anti-oxidant, anti-inflammatory, and regenerative effects across multiple tissue types, including skin and potentially internal tissues
Possible side effects of allopurinol include rash, digestive upset, and elevated liver enzymes (Xu 2013)
